Hubei
Hubei
Hubei, Xiangyang, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma | B-cell Lymphoma Recurrent; B-cell Lymphoma Refractory; NK Cell | Not yet recruiting | Phase 1 / Phase 2 | 2023-06-22 | NCT05909098 |